Clinical Trials

NCT02420847 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
57 Participants

Ixazomib Citrate With Gemcitabine Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Urothelial Cancer That is Metastatic or Cannot Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-07-03
Completion: 2025-12-31
Conditions
Metastatic Urothelial Carcinoma Transitional Cell Carcinoma Unresectable Transitional Cell Carcinoma
Interventions
DRUG
No Results Yet
NCT02381886 | ACTIVE_NOT_RECRUITING | PHASE1
166 Participants

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-03-06
Completion: 2016-12-07
Conditions
Advanced Malignancies That Harbor IDHR132 Mutations
Interventions
DRUG
No Results Yet
NCT02354014 | RECRUITING | PHASE2
60 Participants

Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents Pulmonary MDR-TB

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-05-03
Completion: 2027-02-11
Conditions
Multidrug-Resistant Tuberculosis
Interventions
DRUG
No Results Yet
NCT02337985 | ACTIVE_NOT_RECRUITING | PHASE1
10 Participants

Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-11-20
Completion: 2026-09-08
Conditions
AIDS-Related Burkitt Lymphoma AIDS-Related Diffuse Large B-cell Lymphoma AIDS-Related Plasmablastic Lymphoma AIDS-Related Primary Effusion Lymphoma HIV Infection AIDS Related Non-Hodgkin Lymphoma
Interventions
DRUG BIOLOGICAL
No Results Yet
NCT02321501 | ACTIVE_NOT_RECRUITING | PHASE1
37 Participants

Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-06-22
Completion: 2026-12-31
Conditions
ALK Positive Locally Advanced Malignant Solid Neoplasm Metastatic Malignant Solid Neoplasm ROS1 Gene Rearrangement Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
DRUG OTHER
No Results Yet
NCT02311933 | ACTIVE_NOT_RECRUITING | PHASE2
81 Participants

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-05-28
Completion: 2020-11-06
Conditions
Recurrent Breast Carcinoma Stage III Breast Cancer AJCC v7 Stage IIIA Breast Cancer AJCC v7 Stage IIIB Breast Cancer AJCC v7 Stage IIIC Breast Cancer AJCC v7 Stage IV Breast Cancer AJCC v6 and v7
Interventions
DRUG OTHER
NCT02280161 | RECRUITING
2000 Participants

Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2014-09-16
Completion: 2026-09-16
Conditions
Malignant Neoplasm
Interventions
OTHER
No Results Yet
NCT02253316 | ACTIVE_NOT_RECRUITING | PHASE2
236 Participants

Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-01-20
Completion: 2020-02-05
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL DRUG
NCT02210117 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
104 Participants

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-11-25
Completion: 2025-12-31
Conditions
Clear Cell Renal Cell Carcinoma Metastatic Kidney Carcinoma Stage IV Renal Cell Cancer AJCC v7
Interventions
BIOLOGICAL PROCEDURE OTHER
No Results Yet
NCT02180867 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
140 Participants

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-07-11
Completion: 2019-06-30
Conditions
Alveolar Soft Part Sarcoma Angiomatoid Fibrous Histiocytoma Atypical Fibroxanthoma Clear Cell Sarcoma of Soft Tissue Epithelioid Malignant Peripheral Nerve Sheath Tumor Epithelioid Sarcoma Extraskeletal Myxoid Chondrosarcoma Extraskeletal Osteosarcoma Fibrohistiocytic Neoplasm Fibrosarcoma Inflammatory Myofibroblastic Tumor Intimal Sarcoma Leiomyosarcoma Liposarcoma Liver Embryonal Sarcoma Low Grade Fibromyxoid Sarcoma Low Grade Myofibroblastic Sarcoma Malignant Peripheral Nerve Sheath Tumor Malignant Skin Granular Cell Tumor Malignant Triton Tumor Mesenchymal Chondrosarcoma Myxofibrosarcoma Myxoid Chondrosarcoma Myxoinflammatory Fibroblastic Sarcoma Nerve Sheath Neoplasm PEComa Pericytic Neoplasm Plexiform Fibrohistiocytic Tumor Sclerosing Epithelioid Fibrosarcoma Skin Glomus Tumor Stage IB Soft Tissue Sarcoma AJCC v7 Stage IIB Soft Tissue Sarcoma AJCC v7 Stage III Soft Tissue Sarcoma AJCC v7 Stage IV Soft Tissue Sarcoma AJCC v7 Synovial Sarcoma Undifferentiated High Grade Pleomorphic Sarcoma of Bone
Interventions
DRUG RADIATION PROCEDURE
NCT02179086 | ACTIVE_NOT_RECRUITING | PHASE2
606 Participants

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-12-04
Completion: 2025-12-31
Conditions
Glioblastoma
Interventions
RADIATION OTHER DRUG
No Results Yet
NCT02123758 | ACTIVE_NOT_RECRUITING | PHASE1
57 Participants

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-07-09
Completion: 2016-06-27
Conditions
Prostatic Neoplasms Metastatic Castration-Resistant Prostate Cancer
Interventions
DRUG
No Results Yet
NCT02107989 | RECRUITING
700 Participants

Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2014-03-11
Completion: 2028-03-30
Conditions
Epilepsy
Interventions
DEVICE
No Results Yet
NCT02003222 | ACTIVE_NOT_RECRUITING | PHASE3
488 Participants

Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-05-19
Completion: 2023-06-23
Conditions
Acute Lymphoblastic Leukemia B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative
Interventions
PROCEDURE BIOLOGICAL DRUG
NCT01964859 | RECRUITING | PHASE2
80 Participants

Feasibility Study for Fibroblast Autologous Skin Grafts

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2015-01-07
Completion: 2027-12-02
Conditions
Wounds and Injuries
Interventions
BIOLOGICAL
No Results Yet
NCT01962636 | RECRUITING | NA
200 Participants

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-12-31
Completion: 2026-02-28
Conditions
Acute Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelofibrosis Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large B Cell Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin Lymphoma Multiple Myeloma
Interventions
DRUG RADIATION BIOLOGICAL
No Results Yet
NCT01955499 | ACTIVE_NOT_RECRUITING | PHASE1
39 Participants

Lenalidomide and Ibrutinib in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-09-24
Completion: 2024-11-06
Conditions
Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Marginal Zone Lymphoma
Interventions
PROCEDURE DRUG
No Results Yet
NCT01950390 | ACTIVE_NOT_RECRUITING | PHASE2
169 Participants

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-01-24
Completion: 2021-10-06
Conditions
Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7 Unresectable Melanoma
Interventions
BIOLOGICAL
NCT01934660 | COMPLETED
150 Participants

Links Between Inflammation and Cardiometabolic Diseases

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2013-12-02
Completion: 2022-08-03
Conditions
Diabetes Mellitus Cardiovascular Disease Healthy Volunteer Inflammation
Interventions
DRUG
No Results Yet
NCT01909245 | ACTIVE_NOT_RECRUITING | PHASE2
10 Participants

Islet Cell Transplant for Type 1 Diabetes

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-10-16
Completion: 2026-09-22
Conditions
Type 1 Diabetes Mellitus
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT01886872 | ACTIVE_NOT_RECRUITING | PHASE3
547 Participants

Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-01-15
Completion: 2018-08-07
Conditions
Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia
Interventions
DRUG PROCEDURE OTHER BIOLOGICAL
NCT01867411 | COMPLETED
159 Participants

Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2013-11-06
Completion: 2024-06-29
Conditions
Nicotine Dependence
No Results Yet
NCT01856192 | ACTIVE_NOT_RECRUITING | PHASE2
349 Participants

Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-08-27
Completion: 2020-03-26
Conditions
Ann Arbor Stage II Diffuse Large B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
Interventions
DRUG OTHER BIOLOGICAL
NCT01850888 | COMPLETED | NA
15 Participants

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-12-31
Completion: 2025-10-20
Conditions
Relapsed Neuroblastoma Metastatic Pheochromocytoma
Interventions
DRUG PROCEDURE
No Results Yet
NCT01841736 | ACTIVE_NOT_RECRUITING | PHASE2
171 Participants

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-09-20
Completion: 2019-03-05
Conditions
Foregut Neuroendocrine Tumor Hindgut Neuroendocrine Tumor Metastatic Digestive System Neuroendocrine Tumor G1 Metastatic Neuroendocrine Tumor Midgut Neuroendocrine Tumor G1 Neuroendocrine Tumor G2 Recurrent Digestive System Neuroendocrine Tumor G1 Regional Digestive System Neuroendocrine Tumor G1
Interventions
PROCEDURE OTHER DRUG
NCT01804686 | RECRUITING | PHASE3
700 Participants

A Long-term Extension Study of PCI-32765 (Ibrutinib)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-09-09
Completion: 2026-12-31
Conditions
Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Diffuse Large B-cell Lymphoma Waldenstrom Macroglobulinemia Chronic Graft Versus Host Disease
Interventions
DRUG
No Results Yet
NCT01754363 | ACTIVE_NOT_RECRUITING | NA
1542 Participants

Survivorship of Attune Primary Total Knee Prosthesis

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-02-01
Completion: 2030-02-01
Conditions
Noninflammatory Degenerative Joint Disease
Interventions
DEVICE
No Results Yet
NCT01712490 | ACTIVE_NOT_RECRUITING | PHASE3
1334 Participants

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2012-11-09
Completion: 2017-04-20
Conditions
Hodgkin Lymphoma
Interventions
DRUG
NCT01708954 | ACTIVE_NOT_RECRUITING | PHASE2
125 Participants

Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-02-13
Completion: 2015-08-14
Conditions
Recurrent Lung Non-Small Cell Carcinoma Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions
DRUG OTHER
NCT01628029 | ACTIVE_NOT_RECRUITING | PHASE2
68 Participants

Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2014-01-15
Completion: 2025-12-31
Conditions
Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Sleep Disorder
Interventions
OTHER DRUG PROCEDURE
No Results Yet
NCT01621581 | COMPLETED | PHASE1
25 Participants

AAV2-GDNF for Advanced Parkinson s Disease

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2013-03-13
Completion: 2022-02-04
Conditions
Parkinson's Disease
Interventions
GENETIC
No Results Yet
NCT01512888 | SUSPENDED | PHASE1/PHASE2
28 Participants

Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2016-08-17
Completion: 2026-08-31
Conditions
Severe Combined Immunodeficiency Disease, X-linked
Interventions
GENETIC DRUG DEVICE
No Results Yet
NCT01472094 | ACTIVE_NOT_RECRUITING
700 Participants

The Hurria Older PatiEnts (HOPE) With Breast Cancer Study

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2011-09-09
Completion: 2018-12-02
Conditions
Breast Cancer
No Results Yet
NCT01453660 | ACTIVE_NOT_RECRUITING
44 Participants

Acute Changes in Endothelial Function in Germ Cell Tumor Patients Treated With Cisplatin and Untreated Germ Cell Tumor Controls

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2011-10-11
Completion: 2026-10-31
Conditions
Germ Cell Cancer
Interventions
OTHER
No Results Yet
NCT01446133 | ACTIVE_NOT_RECRUITING | PHASE2
120 Participants

Combination of Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL-SLL)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2011-12-12
Completion: 2025-11-30
Conditions
Leukemia Lymphoma
Interventions
DRUG
No Results Yet
NCT01306019 | RECRUITING | PHASE1/PHASE2
40 Participants

Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2012-09-25
Completion: 2032-12-31
Conditions
X-linked Severe Combined Immunodeficiency (XSCID)
Interventions
BIOLOGICAL DRUG
No Results Yet
NCT01287156 | COMPLETED
1328 Participants

Evaluation and Diagnosis of Potential Research Subjects With Traumatic Brain Injury

Study Type: OBSERVATIONAL
Last Updated: 2025-11-10
Start Date: 2013-01-10
Conditions
Traumatic Brain Injury
No Results Yet
NCT01286272 | COMPLETED | PHASE2
135 Participants

Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2011-04-28
Completion: 2017-05-24
Conditions
Ann Arbor Stage III Grade 1 Follicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma Grade 3a Follicular Lymphoma
Interventions
DRUG RADIATION OTHER BIOLOGICAL PROCEDURE
NCT01274338 | ACTIVE_NOT_RECRUITING | PHASE3
1673 Participants

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2011-05-25
Completion: 2019-02-15
Conditions
Melanoma of Unknown Primary Recurrent Melanoma Stage IIIB Cutaneous Melanoma AJCC v7 Stage IIIC Cutaneous Melanoma AJCC v7 Stage IV Cutaneous Melanoma AJCC v6 and v7
Interventions
BIOLOGICAL OTHER
NCT01272037 | ACTIVE_NOT_RECRUITING | PHASE3
5018 Participants

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Study Type: INTERVENTIONAL
Last Updated: 2025-11-10
Start Date: 2011-01-15
Completion: 2023-02-01
Conditions
Breast Ductal Carcinoma In Situ Invasive Breast Carcinoma Multicentric Breast Carcinoma Multifocal Breast Carcinoma Synchronous Bilateral Breast Carcinoma
Interventions
DRUG OTHER
Previous
Sorted by latest updates
Next
Showing 40 trials per page ยท Total 557382 trials